48,460
edits
(→Order of Gleason score components changed: +upgrade based on nodule) |
|||
(4 intermediate revisions by the same user not shown) | |||
Line 19: | Line 19: | ||
***A biopsy with 98% Gleason pattern 4 and 2% Gleason pattern 3 would be graded as 8/10 (4+4). | ***A biopsy with 98% Gleason pattern 4 and 2% Gleason pattern 3 would be graded as 8/10 (4+4). | ||
*Reported as on prostatectomies as: (primary pattern) + (secondary pattern) = sum, (tertiary pattern) | *Reported as on prostatectomies as: (primary pattern) + (secondary pattern) = sum, (tertiary pattern) | ||
====When to use/not to use==== | |||
The ''College of American Pathologist'' synoptic (''Cancer Protocol Template'') says:<ref>Srigley JR ''et al.'', "Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland", College of American Pathologists, Version: 4.0.3.0. (June 2017), Accessed on: 10 October 2018.</ref> | |||
*Grade all prostate specimens with adenocarcinoma except those with prior treatment changes (e.g. radiation therapy changes or anti-androgen changes). | |||
====Tertiary Gleason pattern==== | ====Tertiary Gleason pattern==== | ||
Line 321: | Line 325: | ||
*[[Prostate cancer staging]]. | *[[Prostate cancer staging]]. | ||
*[[Cancer staging systems]]. | *[[Cancer staging systems]]. | ||
*[[Cribriform pattern within invasive prostate carcinoma]]. | |||
*[[Apparent diffusion coefficient]]. | |||
==References== | ==References== |
edits